Xenon Pharmaceuticals Inc (XENE) — Capital Reinvestment Ratio
Latest as of December 2019:
0.03x
Xenon Pharmaceuticals Inc (XENE) has a Capital Reinvestment Ratio of 0.03x as of December 2019, meaning it reinvests 0% of its operating cash flow ($19.73 Million) in capital expenditures ($595.00K). See XENE cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.03x
Capex / Operating Cash Flow
Operating Cash Flow
$19.73 Million
USD
Capital Expenditures
$595.00K
USD
Data as of
Dec 2019
Most recent filing
Xenon Pharmaceuticals Inc Capital Reinvestment Ratio (2012–2014)
This chart tracks Xenon Pharmaceuticals Inc's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Xenon Pharmaceuticals Inc (2012–2014)
Year-by-year Capital Reinvestment Ratio for Xenon Pharmaceuticals Inc from 2012 to 2014. For live market cap and broader valuation context, see XENE stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2014 | 5.75x | $266.00K | $1.53 Million | ▲ +49702.1% |
| 2012 | 0.01x | $45.57 Million | $526.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow